Skip to content

Role of Ayurveda medicine in Degenrativve brain disoders

Efficacy of Brhami Ghrita in Mild Neuro Cognitive disorder -A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020596
Enrollment
40
Registered
2019-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F99- Mental disorder, not otherwise specified

Interventions

Intervention1: Intervention: Brahmi Ghrita will be administer to the patient orally 10ml BD Before food for 90 days Control Intervention1: Donepezil: Tab Donepezil 10mg OD orally after food for 90days

Sponsors

Dr Himani Negi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age above 60 years of either sex. Diagnosed as Mild Neurocognitive Disorder criteria with sub types of Alzheimerâ??s disease, Frontotemporal lobar degeneration, Lewy body disease, Vascular disease as per DSM V criteria Mini Mental State Examination (MMSE)

Exclusion criteria

Exclusion criteria: Other Neuro cognitive disorders due to Parkinsonâ??s disease, trauma, medical conditions etc. Substantial neuropsychiatric or behavioral symptoms. Patients with severe or uncontrolled somatic disorders will be excluded. Patients with clinically relevant depression (CSDD >10). Patient on any other medications like psychotropic, neurotropic etc since 4 weeks. Patient with substance abuse like alcohol, tobacco etc

Design outcomes

Primary

MeasureTime frame
Patients administered with Brahmi Ghrita is more efficacious compared to DonepezilTimepoint: 0th, 30th, 60th, 90th day

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDr Basavraj Tubaki

KAHERs Shri B M K Ayurveda Mahavidyalaya

himaninegi500@gmail.com6398153308

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026